Literature DB >> 24767768

Respiratory microbiome in IPF: cause, effect, or biomarker?

Philip L Molyneaux1, Toby M Maher2.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 24767768     DOI： 10.1016/S2213-2600(14)70088-8

Source DB:  PubMed          Journal:  Lancet Respir Med        ISSN： 2213-2600            Impact factor:   30.700


× No keyword cloud information.
  12 in total

Review 1.  Lung microbial-host interface through the lens of multi-omics.

Authors:  Shivani Singh; Jake G Natalini; Leopoldo N Segal
Journal:  Mucosal Immunol       Date:  2022-07-06       Impact factor: 8.701

Review 2.  Mechanistic and Technical Challenges in Studying the Human Microbiome and Cancer Epidemiology.

Authors:  Mukesh Verma
Journal:  Technol Cancer Res Treat       Date:  2016-06-22

Review 3.  Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs.

Authors:  Yohannes T Ghebre; Ganesh Raghu
Journal:  Am J Respir Crit Care Med       Date:  2016-06-15       Impact factor: 21.405

4.  The role of bacteria in the pathogenesis and progression of idiopathic pulmonary fibrosis.

Authors:  Phillip L Molyneaux; Michael J Cox; Saffron A G Willis-Owen; Patrick Mallia; Kirsty E Russell; Anne-Marie Russell; Elissa Murphy; Sebastian L Johnston; David A Schwartz; Athol U Wells; William O C Cookson; Toby M Maher; Miriam F Moffatt
Journal:  Am J Respir Crit Care Med       Date:  2014-10-15       Impact factor: 30.528

Review 5.  The Lung Microbiome in Idiopathic Pulmonary Fibrosis: A Promising Approach for Targeted Therapies.

Authors:  Aline Fastrès; Florence Felice; Elodie Roels; Catherine Moermans; Jean-Louis Corhay; Fabrice Bureau; Renaud Louis; Cécile Clercx; Julien Guiot
Journal:  Int J Mol Sci       Date:  2017-12-16       Impact factor: 5.923

6.  Bacterial burden in the lower airways predicts disease progression in idiopathic pulmonary fibrosis and is independent of radiological disease extent.

Authors:  Rachele Invernizzi; Joseph Barnett; Bhavin Rawal; Arjun Nair; Poonam Ghai; Shaun Kingston; Felix Chua; Zhe Wu; Athol U Wells; Elizabeth R Renzoni; Andrew G Nicholson; Alexandra Rice; Clare M Lloyd; Adam J Byrne; Toby M Maher; Anand Devaraj; Philip L Molyneaux
Journal:  Eur Respir J       Date:  2020-04-03       Impact factor: 16.671

Review 7.  The Role of Infection in Interstitial Lung Diseases: A Review.

Authors:  Natalya Azadeh; Andrew H Limper; Eva M Carmona; Jay H Ryu
Journal:  Chest       Date:  2017-04-08       Impact factor: 9.410

Review 8.  The role of viral and bacterial infections in the pathogenesis of IPF: a systematic review and meta-analysis.

Authors:  Shayan Mostafaei; Babak Sayad; Maryam Ebadi Fard Azar; Mohammad Doroudian; Shima Hadifar; Ava Behrouzi; Parisa Riahi; Bashdar Mahmud Hussen; Bahareh Bayat; Javid Sadri Nahand; Mohsen Moghoofei
Journal:  Respir Res       Date:  2021-02-12

Review 9.  Clinical Genetics in Interstitial Lung Disease.

Authors:  Chad A Newton; Philip L Molyneaux; Justin M Oldham
Journal:  Front Med (Lausanne)       Date:  2018-04-26

Review 10.  The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.

Authors:  Paolo Spagnolo; Philip L Molyneaux; Nicol Bernardinello; Elisabetta Cocconcelli; Davide Biondini; Federico Fracasso; Mariaenrica Tiné; Marina Saetta; Toby M Maher; Elisabetta Balestro
Journal:  Int J Mol Sci       Date:  2019-11-10       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.